Guidance language strengthened, with the company raising full year leasing and Capital Markets revenue growth forecasts, along with a higher adjusted EPS growth target of 25%-35%, compared to the ...

DuPont de Nemours, Inc. posts strong Q2 results, boosts guidance, and prepares for the Qnity spin-off, unlocking growth ...

Q2 2025 Management View Juan Ricardo Luciano, CEO, highlighted that ADM reported adjusted earnings per share of $0.93 and total segment operating profit of $830 million for the quarter. Luciano ...

Q2 2025 Management View CEO David L. King reported, “Primoris had a record second quarter, achieving new highs in the revenue, operating income and earnings.” King emphasized the company’s ability to ...

Key Points Adjusted earnings per share rose to $1.36 (non-GAAP) in Q2 2025, beating the $1.14 non-GAAP EPS estimate and up 20% year over year. The company completed a major variable annuity ...

Should you add this global product design and technology company to your portfolio, hold your position or sell the stock? Whether you're a long-term shareholder or a potential investor looking to ...

The company posted adjusted earnings per share of $1.12 for Q2 2025, above analyst expectations of $1.06 (non-GAAP), and GAAP revenue of $3,257 million for Q2 2025, narrowly topping the $3,239.93 ...

The company assessed goodwill for impairment and recorded a $77 million noncash impairment charge in the pain management and ...

Pfizer's second-quarter 2025 results exceeded expectations with a 10% revenue growth and an adjusted EPS of $0.78.

U.S. commercial revenue skyrocketed 93% year over year on phenomenal demand for the company's artificial intelligence ...

BP reported strong Q2 2025 earnings, with adjusted EPS of $0.90 per share beating expectations. Revenue fell short at $46.63 ...